The injection is the generic therapeutic equivalent of the US Food and Drug Administration (US FDA)-approved Lexiscan (Regadenoson) injection. To test the heart for coronary artery disease, the injection is utilised.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZPhXGVw
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Dr. Reddy's Laboratories launches Regadenoson Injection 0.4mg/5mL in US market
https://ift.tt/meIcNo0
No comments:
Post a Comment